We are developing microbiota derived therapeutics that enhance cognitive performance (P), build cognitive resilience (R), prevent cognitive decline and dementia (MCI), and slow Alzheimer’s disease progression (AD).

— The CogniBiome Platform.

We identify and harness Mediterranean diet-driven and human-validated microbial functional states that optimize brain performance and cognitive health. Our platform supports both performance enhancement and disease-modifying therapeutic programs.